11.18.2024 - Extended Benefit
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Episode 240 of the QuadShot News Podcast podcast, hosted by Sam Marcrom, Laura Dover, Caleb Dulaney, titled "11.18.2024 - Extended Benefit" was published on November 18, 2024 and runs 9 minutes.
November 18, 2024 ·9m · QuadShot News Podcast
Summary
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Episode Description
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Check out the website and subscribe to the newsletter!
www.quadshotnews.com
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
Similar Episodes
Mar 3, 2025 ·3m
Apr 2, 2018 ·8m
Mar 28, 2018 ·0m
Sep 7, 2017 ·4m
Aug 31, 2017 ·13m
Jul 13, 2017 ·3m